Press Releases

Filter

February 18, 2026

Canopy Growth Announces MTL Cannabis Shareholder Approval of Acquisition

SMITHS FALLS, ON, February 18, 2026 — Canopy Growth Corporation (“Canopy Growth” or the “Company”) (TSX: WEED) (Nasdaq: CGC) is pleased to announce that shareholders of MTL Cannabis Corp. (“MTL Cannabis” or “MTL”) have voted to approve the Company’s previously announced acquisition of MTL (the “Transaction”) at a special meeting of shareholders of MTL (the “MTL Shareholders”) held February 17, 2026. The plan of arrangement with Canopy Growth received overwhelming support from MTL Shareholders, with (i) 99.97% of all shares of MTL (the “MTL Shares”) cast in favour of the special resolution approving the Transaction, and (ii) 99.80% of MTL Shares,…

February 6, 2026

Canopy Growth Reports Third Quarter Fiscal 2026 Financial Results; Delivers double digit net revenue growth in Canada Cannabis contributing to a narrowing net loss; financial strength of $371M in cash and cash equivalents with a net cash position of $146M at December 31, 2025

Net loss in Q3 FY2026 narrowed by 49% year-over-year; Adjusted EBITDA1 loss narrowed by 17% year-over-year, resulting from strong sales execution and SG&A cost savings Acquisition of MTL Cannabis remains on track to close in the current quarter. Transaction is expected to strengthen Canopy Growth’s global cannabis platform Strategic recapitalization completed in January 2026 further strengthened balance sheet, with maturity dates for all outstanding indebtedness in 2031 Read our third quarter fiscal year 2026 financial results here: SMITHS FALLS, ON, February 6, 2026 – Canopy Growth Corporation (“Canopy Growth” or the “Company”) (TSX: WEED) (Nasdaq: CGC) today announced its financial results for the…

January 23, 2026

Canopy Growth to Report Third Quarter Fiscal 2026 Financial Results on February 6, 2026

Smiths Falls, ON, January 23, 2026 – Canopy Growth Corporation (“Canopy Growth” or the “Company”) (TSX:WEED, NASDAQ:CGC) will release its financial results for the third quarter fiscal year 2026 ended December 31, 2025 before financial markets open on February 6, 2026. Following the release of its third quarter fiscal year 2026 financial results, Canopy Growth will host an audio webcast with Luc Mongeau, CEO and Tom Stewart, CFO on February 6, 2026 at 10 AM Eastern Time (ET). Webcast Information A live audio webcast will be available at: https://onlinexperiences.com/Launch/QReg/ShowUUID=45C34153-5530-4D6A-A742-BC34AD2534FA Replay Information A replay will be accessible by webcast until 11:59…

January 8, 2026

Canopy Growth Announces Strategic Recapitalization Transactions Significantly Strengthening Balance Sheet to Support Growth Strategy

This news release constitutes a “designated news release” for the purposes of Canopy Growth’s prospectus supplement dated August 29, 2025 to its short form base shelf prospectus dated June 5, 2024 Refinances Term Loan due 2027 and Exchanges Convertible Debentures due 2029, Extending Maturities of All Outstanding Indebtedness to Earliest January 2031 While Enhancing Liquidity Profile SMITHS FALLS, ON. January 8, 2026 — Canopy Growth Corporation (“Canopy Growth” or the “Company”) (TSX: WEED) (Nasdaq: CGC), a world-leading cannabis company dedicated to unleashing the power of cannabis to improve lives, announced today that the Company has entered into a series of transactions…

December 15, 2025

Canopy Growth to Acquire MTL Cannabis; Transaction Expected to Create Canada’s Leading Medical Cannabis Business and Enhance Capacity to Serve Growing International Demand

This news release constitutes a “designated news release” for the purposes of Canopy Growth’s prospectus supplement dated August 29, 2025 to its short form base shelf prospectus dated June 5, 2024 All financial amounts in this press release are expressed in Canadian dollars. Highly accretive business combination expected to generate significant run-rate synergies of approximately $10 million within 18 months Strengthens Canopy Growth’s presence in Québec with an opportunity to expand national distribution of MTL’s high-quality, budtender-recommended product portfolio2 MTL’s core management team is expected to join Canopy Growth to drive cultivation excellence and enhance the Company’s product quality…

December 4, 2025

Canopy Growth Launches Claybourne Gassers Liquid Diamonds All-In-One Vapes in Canada, Expanding Footprint in High-Growth Vape Segment

New high-performance AIO vapes and infused pre-roll variety packs further Claybourne’s continued growth as one of the fastest-rising brands[1] in Canada’s adult-use market SMITHS FALLS, ON, December 4, 2025 – Canopy Growth Corporation (“Canopy Growth” or the “Company”) (TSX: WEED) (Nasdaq: CGC), a world-leading cannabis company dedicated to unleashing the power of cannabis to improve lives, today announced the national launch of Claybourne Gassers, a new lineup of All-in-One (AIO) vapes featuring liquid diamonds. The launch marks Claybourne’s entry into Canada’s vape categorybuilding on its leadership in high potency infused products. The Claybourne Gassers collection includes three 0.95g liquid diamond…

November 18, 2025

Canopy Growth Expands Spectrum Therapeutics Portfolio in Australia with New Softgels

Expanded formats strengthen Canopy Growth’s medical offering as patient demand rises SMITHS FALLS, ON, November 18, 2025 – Canopy Growth Corporation (“Canopy Growth” or the “Company”) (TSX: WEED) (Nasdaq: CGC), a world-leading cannabis company dedicated to unleashing the power of cannabis to improve lives, has expanded its Spectrum Therapeutics portfolio in Australia with the availability of new softgel capsules, further enhancing the Company’s medical cannabis offerings in the region. The formats include Spectrum Yellow Cannabis Oil Softgels (CBD 20mg), Spectrum Red Cannabis Oil Softgels (THC 10mg), and Spectrum Blue Cannabis Oil Softgels (Balanced THC 2.5mg : CBD 3.75mg). These softgels…

November 7, 2025

Canopy Growth Reports Second Quarter Fiscal 2026 Financial Results; Company Continues to Strengthen Financial Performance with Improving Adjusted EBITDA, Disciplined Cost Management, and a Stronger Balance Sheet

Canada adult-use revenue up 30% in Q2 FY2026 and 37% year-to-date, reflecting the benefits of our focused commercial strategy and more disciplined execution Canada medical revenue up 17% in Q2 FY2026 and 15% year-to-date, marking another standout quarter for growth $298MM cash and cash equivalents, which exceeds debt balances by $70MM at September 30, 2025; as a result, conditions that previously raised substantial doubt concerning the Company’s ability to continue as a going concern have been resolved SMITHS FALLS, ON, November 7, 2025 – Canopy Growth Corporation (“Canopy Growth” or the “Company”) (TSX:WEED) (Nasdaq: CGC) today announced its financial results…

October 24, 2025

Canopy Growth to Report Second Quarter Fiscal 2026 Financial Results on November 7, 2025

Smiths Falls, ON, October 24, 2025 – Canopy Growth Corporation (“Canopy Growth” or the “Company”) (TSX:WEED, NASDAQ:CGC) will release its financial results for the second quarter fiscal year 2026 ended September 30, 2025 before financial markets open on November 7, 2025. Following the release of its second quarter fiscal year 2026 financial results, Canopy Growth will host an audio webcast with Luc Mongeau, CEO and Tom Stewart, CFO on November 7, 2025 at 10 AM Eastern Time (ET). Webcast Information A live audio webcast will be available at: https://onlinexperiences.com/Launch/QReg/ShowUUID=EEDC9A65-53FA-40BD-9644-D3ABDCF91E72 Replay Information A replay will be accessible by webcast until 11:59…

October 14, 2025

Canopy Growth Announces Results of Annual General and Special Meeting of Shareholders

SMITHS FALLS, ON, SEPTEMBER 26, 2023 – Canopy Growth Corporation (“Canopy Growth” or the “Company”) (TSX: WEED) (Nasdaq: CGC), a world-leading diversified cannabis company, today announced the voting results from its annual general and special meeting of shareholders held on September 25, 2023 (the “Meeting”). A total of 350,593,653 common shares of the Company (the “Shares”), representing 48.88% of the issued and outstanding Shares, were voted in connection with the Meeting by the Company’s shareholders and proxy holders. All of the matters put forward before the Company’s shareholders for consideration and approval, as set out in the Company’s definitive proxy…

October 8, 2025

Canopy Growth Announces DOJA as Dedicated Canadian Medical Facility

Kelowna site to produce craft cannabis under the DOJA brand exclusively for Spectrum Therapeutics patients, advancing Canopy Growth’s commitment to Canada’s medical market SMITHS FALLS, ON, October 8, 2025 – Canopy Growth Corporation (“Canopy Growth” or the “Company”) (TSX: WEED) (Nasdaq: CGC), a world-leading cannabis company dedicated to unleashing the power of cannabis to improve lives, today announced that its DOJA facility in Kelowna, British Columbia is now operating exclusively as a medical cultivation site supporting the Company’s Spectrum Therapeutics portfolio in Canada. The Kelowna facility will cultivate small-batch, BC-grown craft cannabis under the DOJA brand, available only to registered…

September 26, 2025

Canopy Growth Corporation Announces Adjournment of Annual General and Special Meeting of Shareholders Due to Lack of Quorum

Annual General and Special Meeting of Shareholders of Canopy Growth to be reconvened on October 10 at 1:00 PM ET Canopy Growth shareholders now have until 1:00 PM ET on October 8 to vote Your Vote is Important! If you need assistance with voting your shares please contact Laurel Hill Advisory Group at 1-877-452-7184 or by e-mail at assistance@laurelhill.com SMITHS FALLS, ON, September 26, 2025 — Canopy Growth Corporation (“Canopy Growth” or the “Company”) (TSX:WEED) (NASDAQ:CGC) today announced that, due to the requisite quorum not being present, the annual general and special meeting of shareholders (the “Meeting”) scheduled for September 26,…
Scroll to Top
This site is registered on wpml.org as a development site. Switch to a production site key to remove this banner.